What Multicare Pharmaceuticals Philippines does

Multicare Pharmaceuticals Philippines, Inc. is a Makati City-based, privately-held pharmaceutical distributor and license holder serving the Philippine market as a wholly-owned subsidiary of India's Lupin Ltd. (since 2009). It was established in 1998 as a division of Astra Philippines Inc., became independent in 2002 under founder Romeo Sia Sy, and is positioned among the top 5 branded generic companies in the Philippines with 23+ years of operating history.

Its portfolio comprises prescription medicines, over-the-counter (OTC) consumer health products, biosimilars and innovator products across 12+ therapeutic areas: Diabetes, Oncology, Neuroscience, Gastroenterology, Anti-Infectives, Respiratory, Rheumatology, Critical Care, Women's Health, Orthopedic/Pain, Probiotic and Multi-Channel Consumer Health. Representative products include Glaritus (insulin glargine), Lupigliptin/Lupizin (oral antidiabetics), Abingem 1G and Anzol (oncology), Multivent and Neumoterol (respiratory), Albutein and Plasbumin (critical care plasma products), and consumer brands such as Sorbifer Plus, Calvit, Floracap and Tamipro. Manufacturing is not local; the company markets and distributes formulations via Lupin's global network of 15 manufacturing sites and 7 research centers, supplemented by licensing and business development.

The business model is a sales-led, multi-channel branded generics and consumer health franchise. Revenue is generated through one-time product sales across (i) direct field sales to hospitals and healthcare institutions, (ii) channel partnerships with the three major Philippine retail pharmacy chains (Watsons, Rose Pharmacy, Mercury Drug), (iii) government healthcare procurement, and (iv) e-commerce storefronts on Lazada and Shopee for OTC/consumer health. Pricing is not publicly disclosed; prescriber engagement, medical representatives, multi-channel consumer marketing, and Lupin-backed supply reliability are the stated value drivers.

Name

Multicare Pharmaceuticals Philippines

Legal name

Multicare Pharmaceuticals Philippines, Inc.

Website

https://multicare.com.ph

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

251–500 employees

Short description

Multicare Pharmaceuticals Philippines is a Lupin Ltd. subsidiary and top-5 Philippine branded generics company distributing prescription medicines, OTCs, biosimilars and consumer health supplements across 12+ therapeutic areas via hospitals, three major retail pharmacy chains, government accounts, and Lazada/Shopee e-commerce.

Ownership category

akta.pro rank

Product category

Pharmaceuticals (Branded Generics)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (4242)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

Keywords

• Branded generic pharmaceuticals
• Prescription medicines
• Over-the-counter products
• Consumer health supplements
• Pharmaceutical distribution

Headquarters

HQ city

Makati

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Branded Generics: Revenue from branded generic pharmaceutical products across 12+ therapeutic segments including diabetes, oncology, neuroscience, gastroenterology, and anti-infectives.
2. OTC/Consumer Health Products: Over-the-counter products and multivitamins sold through retail pharmacies and e-commerce channels.
3. Prescription Medicines: Prescription pharmaceutical products including biosimilars and innovator products sold through hospitals, clinics, and retail pharmacies.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Multicare Pharmaceuticals Philippines manufactures, markets, and distributes a diversified portfolio of branded generic prescription medicines, over-the-counter (OTC) products, biosimilars, and consumer health supplements across 12+ therapeutic areas including diabetes, oncology, neuroscience, gastroenterology, anti-infectives, respiratory, rheumatology, critical care, women's health, and multivitamins. Products are commercialized in the Philippines through hospitals, retail pharmacy chains, government health programs, and e-commerce platforms under its own brand portfolio.

Product overview

Multicare Pharmaceuticals Philippines is a pharmaceutical company offering a diversified portfolio of branded generic medicines, over-the-counter (OTC) products, prescription medicines, and consumer health supplements. The portfolio spans 12+ therapeutic areas including Diabetes (Glaritus, Lupigliptin, Lupigliptin Plus, Lupimet, Lupinsulin, Lupizin), Gastroenterology (Prazole Forte, Prazole I.V., Prazole Plus, Lupibile), Neuroscience (Motrigine, Morcet, Loxx, Lupiprine, Riscare), Oncology (Abingem, Cytobin, Doxocare, Cafonate, Naproplat, Naprocap, Pexate, Zildox, Taceedo, L-Aspase), Anti-Infectives (Cimex, Cimex Plus, Traxan, Triconex Forte), Respiratory (Neumoterol, Provexel NS, Provexel MDI, Multivent), Rheumatology (Coxicare, Furic, Binosto), Critical Care (Albutein, Gamunex-C, Plasbumin, Koate-DVI, Maxifer), Women's Health (Evaprost, Floracap), Consumer Health/Multivitamins (Calvit, Calvit Gold, Calprem, Mosvit Elite, Onima, Sorbifer Plus, Sorbifer Durules, Nausecare, Tamipro, Venocare), and Orthopedic/Pain Management (Pregmax M-75, Calprem). The company serves hospitals, retailers, government accounts, and e-commerce platforms (Lazada, Shopee) as part of its integrated multi-channel distribution strategy.

Differentiator

Problem solved

Functional benefit

Products and services

• ABINGEM 1G Gemcitabine Hydrochloride 1g Lyophilized Powder for Injection, an oncology prescription medicine used for locally advanced or metastatic bladder cancer in combination with cisplatin, adenocarcinoma of the pancreas, and non-small cell lung cancer in combination with cisplatin.
• ALBUTEIN 20% Albumin 10g/50mL solution for critical care, used for emergency treatment of hypovolemic shock, burn therapy, hypoproteinemia, adult respiratory distress syndrome (ARDS), cardiopulmonary bypass, and acute liver failure.
• ALVEDON TABLET 500 MG DC (Direct Compression) Paracetamol 500mg tablet, a consumer health product used for headache, toothache, fever associated with colds, menstrual pain, muscle pain, and flu.
• ANZOL 1 MG Anastrozole 1mg Film-Coated Tablet, an oncology prescription medicine used for the treatment of breast cancer in postmenopausal women.
• ARILAN 5 MG

Quantifiable outcome

• Nearly 5x growth since joining Lupin in 2009
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Lupin Ltd.coreStrategic or Co-development Partner · 1 January 2009Multicare joined Lupin Ltd. in 2009 under the vision of Dr. Desh Bandhu Gupta. Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. The partnership provides Multicare access to Lupin's 15 manufacturing sites, 7 research centers, and 24,000+ professionals globally.
• Bahay ArugaminorOthersCSR partnership with Bahay Aruga, a complimentary halfway house in Ermita, Manila providing shelter for pediatric cancer patients undergoing outpatient treatment at PGH and nearby hospitals. Multicare has conducted outreach for 4 years delivering medicines and basic needs packs.
• Cancer Warrior FoundationminorOthersPartnership with Cancer Warrior Foundation to help young cancer patients in several South Luzon provinces through Multicare Pharma's nationwide CSR efforts.
• BHOLI (Bridging Hopes & Opportunity Linkages Initiative)minorOthersPartnership with BHOLI engaging youth in rebuilding efforts in Misamis Oriental as part of Multicare's nationwide community support programs.
• LazadaminorChannel Partner/ Reseller/ DistributorE-commerce platform partnership for online distribution of consumer health products including Sorbifer Plus, multivitamins, and other OTC products.
• ShopeeminorChannel Partner/ Reseller/ DistributorE-commerce platform partnership for online distribution of consumer health products including Sorbifer Plus, multivitamins, and other OTC products.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Others

• Zuellig Pharma: Zuellig Pharma is the largest pharmaceutical distributor in the Philippines and serves as a logistics and channel partner for many of the same manufacturers and retailers that Multicare supplies directly, making it an adjacent ecosystem peer rather than a competing branded-generics manufacturer.

Broad incumbents

• Abbott Pharmaceuticals Philippines: Abbott Philippines sells prescription and consumer-health products across multiple therapeutic areas, including nutrition and OTC supplements, through the same retail-pharmacy chains (Watsons, Mercury Drug) and hospital channels used by Multicare.
• Sanofi Philippines: Sanofi Philippines sells prescription and consumer-health products (including diabetes and vaccines) through the same retail-pharmacy and hospital channels as Multicare, making it a broad incumbent peer rather than a direct generics rival.
• Merck Philippines: Merck Philippines sells prescription specialty and consumer-health products in oncology, fertility, and OTC supplements, competing for the same prescriber and pharmacist relationships as Multicare in hospitals and retail pharmacies.
• AstraZeneca Pharmaceuticals Philippines: AstraZeneca Philippines is the originator of the Astra Philippines division from which Multicare was spun off in 2002; it now competes in the same hospital and specialty-care channels in oncology, cardiovascular, and respiratory segments.
• Bayer Philippines: Bayer Philippines operates prescription and consumer-health franchises (cardiovascular, women's health, multivitamins) that overlap Multicare's Sorbifer, women's health, and cardiovascular offerings, with similar retail-pharmacy and e-commerce distribution.
• Novartis Philippines: Novartis Philippines sells specialty and primary-care prescription medicines (including oncology and cardiology) through the same hospital and retail channels as Multicare, but as part of a global MNC portfolio rather than a Philippines-focused branded-generics specialist.
• GSK Philippines: GSK Philippines competes with Multicare in respiratory, vaccines, and consumer-health OTC categories through similar pharmacy and hospital channels, though as an MNC with global R&D rather than a Philippines branded-generics operator.
• Pfizer Philippines: Pfizer Philippines operates across prescription, vaccines, and specialty care with broad hospital coverage that overlaps Multicare's oncology, anti-infectives, and primary-care segments, competing for the same prescriber mindshare.

Direct peers

• Unilab (United Laboratories): Unilab is the largest pharmaceutical company in the Philippines and the dominant branded-generics player, making it the closest direct peer to Multicare's branded-generics, OTC, and consumer-health business across the same retail-pharmacy and hospital channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/multicareph
• Facebookfacebook.com/multicarepharmaph
• LinkedInlinkedin.com/company/multicareph
• Instagraminstagram.com/multicareph

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Multicare Pharmaceuticals Philippines